Fancb deficiency impairs hematopoietic stem cell function.

Area of Science:

• Hematology
• Genetics
• Molecular Biology

Background:

• Fanconi anemia (FA) is a rare genetic disorder causing bone marrow failure, congenital abnormalities, and cancer predisposition.
• FANCB (FAAP95) is the sole X-linked gene implicated in FA, highlighting a gap in understanding X-linked FA mechanisms.
• Hematopoietic stem cell (HSC) dysfunction is central to FA pathogenesis, but the specific role of FANCB in HSC maintenance remains unclear.

Purpose of the Study:

• To investigate the role of FANCB in adult hematopoiesis using a mouse model.
• To characterize the impact of Fancb deficiency on hematopoietic stem cell (HSC) function and bone marrow recovery.
• To explore the molecular mechanisms underlying Fancb deficiency-related HSC defects.

Main Methods:

• Hematopoietic stem cell (HSC) and progenitor cell analysis in adult Fancb-deficient (Fancb(-/y)) mice.
• Assessment of HSC quiescence, in vitro progenitor activity, and in vivo repopulating capacity.
• Evaluation of bone marrow sensitivity to DNA cross-linking agents (mitomycin C) and myelotoxic stress (5-fluorouracil).
• RNA sequencing (RNA-seq) analysis of Fancb(-/y) HSC and progenitor cells to identify gene expression alterations.

Main Results:

• Fancb(-/y) mice exhibited decreased HSC quiescence, reduced progenitor activity, and impaired in vivo repopulating capacity.
• The hematopoietic system of Fancb(-/y) mice showed hypersensitivity to mitomycin C, leading to bone marrow failure.
• Fancb(-/y) bone marrow demonstrated slower recovery and reduced tolerance to 5-fluorouracil-induced myelotoxic stress.
• RNA-seq analysis revealed dysregulated expression of genes critical for HSC function and cell cycle regulation in Fancb(-/y) cells.

Conclusions:

• Fancb deficiency critically impairs HSC function and bone marrow maintenance.
• The Fancb(-/y) mouse model is valuable for studying the FA pathway's role in HSC homeostasis.
• This model offers new avenues for understanding FA pathogenesis and potential therapeutic targets, particularly concerning X-linked inheritance.